CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 1/2, Dose-escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of SPK-3006 in Adults With Late-onset Pompe Disease
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04093349
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:06.466995+00:00
- Published At
- 2024-11-27T00:00:00+00:00
- Record Updated At
- 2024-11-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Pompe Disease", "Pompe Disease (Late-onset)", "Glycogen Storage Disease Type 2", "Glycogen Storage Disease Type II", "LOPD", "Lysosomal Storage Diseases", "Acid Maltase Deficiency"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-27"- protocolSection.identificationModule.nctId
"NCT04093349"- protocolSection.identificationModule.officialTitle
"Phase 1/2, Dose-escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of SPK-3006 in Adults With Late-onset Pompe Disease"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.